Weight changes with treatment of type 2 diabetes with pioglitazone, metformin and gficlazide

被引：0
|
作者：
Belcher, G
Edwards, G
Urquhart, R
Eckland, D
Johns, D
Tan, MG
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A111 / A111
页数：1
相关论文
共 50 条
  • [21] Effects of Pioglitazone and Metformin Combination Therapy on High-Molecular-Weight Adiponectin Compared With Metformin Monotherapy in Type 2 Diabetes Mellitus Patients
    Matsushita, Takaya
    Kaji, Akino
    Kaji, Kuniaki
    Takahashi, Eri
    Usui, Takahiro
    Asahi, Nobuteru
    Sato, Tomoya
    Ohono, Atushi
    Ueki, Akio
    DIABETES, 2012, 61 : A626 - A626
  • [22] Tolerability of pioglitazone compared to metformin in patients with Type 2 diabetes mellitus.
    Herz, M
    Tan, MH
    Pavo, I
    Melnichenko, GA
    Shoustov, SB
    Gyimesi, A
    Varkonyi, T
    Johns, D
    Schluchter, BJ
    Widel, M
    DIABETOLOGIA, 2002, 45 : A251 - A252
  • [23] Comparison of vildagliptin and pioglitazone in patients with type 2 diabetes inadequately controlled with metformin
    Bolli, G.
    Dotta, F.
    Colin, L.
    Minic, B.
    Goodman, M.
    DIABETES OBESITY & METABOLISM, 2009, 11 (06): : 589 - 595
  • [24] Empagliflozin as add-on to pioglitazone with or without metformin in patients with Type 2 diabetes
    Kovacs, C. S.
    Seshiah, V.
    Merker, L.
    Christiansen, A. Vedel
    Roux, F.
    Salsali, A.
    Kim, G.
    Stella, P.
    Woerle, H. J.
    Broedl, U. C.
    DIABETIC MEDICINE, 2015, 32 : 88 - 88
  • [25] The efficacy of pioglitazone compared to metformin in drug naive patients with type 2 diabetes
    Schernthaner, G
    Edwards, G
    Lee, C
    Tan, M
    Herz, M
    DIABETES, 2003, 52 : A455 - A455
  • [26] Effect of Pioglitazone Versus Metformin on Cardiovascular Risk Markers in Type 2 Diabetes
    Genovese, Stefano
    De Berardis, Giorgia
    Nicolucci, Antonio
    Mannucci, Edoardo
    Evangelista, Virgilio
    Totani, Licia
    Pellegrini, Fabio
    Ceriello, Antonio
    ADVANCES IN THERAPY, 2013, 30 (02) : 190 - 202
  • [27] Pioglitazone and metformin are equally effective in reduction of chemerin in patients with type 2 diabetes
    Esteghamati, Alireza
    Ghasemiesfe, Mehrnaz
    Mousavizadeh, Mostafa
    Noshad, Sina
    Nakhjavani, Manouchehr
    JOURNAL OF DIABETES INVESTIGATION, 2014, 5 (03) : 327 - 332
  • [28] Effects of Metformin and Pioglitazone on Serum Pentosidine Levels in Type 2 Diabetes Mellitus
    Kanazawa, I.
    Yamamoto, M.
    Yamaguchi, T.
    Sugimoto, T.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2011, 119 (06) : 362 - 365
  • [29] Effect of Pioglitazone Versus Metformin on Cardiovascular Risk Markers in Type 2 Diabetes
    Stefano Genovese
    Giorgia De Berardis
    Antonio Nicolucci
    Edoardo Mannucci
    Virgilio Evangelista
    Licia Totani
    Fabio Pellegrini
    Antonio Ceriello
    Advances in Therapy, 2013, 30 : 190 - 202
  • [30] Comparison of efficacy between Pioglitazone and metformin in treating type 2 diabetes mellitus
    Yu, YR
    Li, YB
    Fan, JY
    Wang, YG
    DIABETES, 2002, 51 : A480 - A480
12345